Supporting Pharmacy Compounding: APC’s Efforts on GLP-1s and Drug Shortages | Newsletter | Issue 14 | 2024

The Alliance for Pharmacy Compounding (APC) is an organization dedicated to supporting the practice of pharmacy compounding. Each year is dedicated to bringing compounding awareness and industry updates in support of continual improvement of patients’ lives. This year, MediZap is pleased to announce our sponsorship of APC. We are excited to support this organization as they continue their mission to promote and protect the practice of pharmacy compounding. APC has done significant work in addressing Drug Shortages and the compounding of GLP-1s. They have updated their statements on the rules governing compounding, FDA guidance, and the permissibility of compounding essential medications during shortages. Additionally, APC has provided accurate information to combat misinformation about GLP-1 compounding and has issued guidelines to ensure safe and effective practices. For more information, please visit the APC website (https://a4pc.org).

  1. Traditional Compounding 101 https://join.a4pc.org/hubfs/Traditional%20Pharmacy%20Compounding%20101.pdf?hsLang=en
  2. APC’s detailed statement on shortage drug compounding and GLP-1s https://a4pc.org/files/APC-Compounded-GLP-1s-Media-Brief-REVISED-11-March-2024.pdf
  3. GLP-1 Compounding Printer https://a4pc.org/files/Semaglutide-Compounding-–-A-Primer-for-Reporters_June-2023.pdf
  4. Our CEO’s commentary on compounded GLP-1 reporting https://a4pc.org/files/Compounded-GLP1s-and-one-handed-reporting-Brunner-April-2024.pdf
  5. APC’s statement in response to claims by Eli Lilly (March 2024) https://a4pc.org/files/APC-CEO-Scott-Brunner-in-Response-to-Eli-Lilly-Open-Letter-03.07.2024.pdf
  6. 2023-2024 Demographic Snapshot of Pharmacy Compounding https://a4pc.org/files/APC-Snapshot-23-24-updated-version.pdf
  7. Town Hall on GLP-1 Compounding recording https://vimeo.com/970174143

MediZap research and development using our proprietary Zap+Test Program has proven ability to use terminal sterilization by E-Beam; moreover, increasing the sterility assurance level (SAL) to 10-6 and extending beyond use dates (BUD).

Download PDF


Older Post Newer Post